Cargando…

A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances

BACKGROUND: Photodynamic therapy (PDT) is a clinically implemented modality to combat malignant tumor, while its efficacy is largely limited by several resistance factors from tumor microenvironment (TME), such as hypoxia, anti-oxidant systems, and ATP-dependent tumor adaptive resistances. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peng, Zhou, Yanbin, Shi, Xinyi, Yuan, Yu, Peng, Ying, Hua, Surong, Luo, Qiange, Ding, Jinsong, Li, Yong, Zhou, Wenhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139056/
https://www.ncbi.nlm.nih.gov/pubmed/34020663
http://dx.doi.org/10.1186/s12951-021-00893-6
_version_ 1783695928564121600
author Liu, Peng
Zhou, Yanbin
Shi, Xinyi
Yuan, Yu
Peng, Ying
Hua, Surong
Luo, Qiange
Ding, Jinsong
Li, Yong
Zhou, Wenhu
author_facet Liu, Peng
Zhou, Yanbin
Shi, Xinyi
Yuan, Yu
Peng, Ying
Hua, Surong
Luo, Qiange
Ding, Jinsong
Li, Yong
Zhou, Wenhu
author_sort Liu, Peng
collection PubMed
description BACKGROUND: Photodynamic therapy (PDT) is a clinically implemented modality to combat malignant tumor, while its efficacy is largely limited by several resistance factors from tumor microenvironment (TME), such as hypoxia, anti-oxidant systems, and ATP-dependent tumor adaptive resistances. The aim of this work is to construct a multifunctional nanoplatform to remodel multiple resistant TME for enhanced PDT. RESULTS: Here, a targeting nano-reactor was facilely constructed to reverse the multiple resistances of PDT by incorporating glucose oxidase (GOx) and chlorin e6 (Ce6) into poly (D, L-lactic-co-glycolic acid) (PLGA)/ metalorganic framework (MOF) coreshell nanoassembly, with surface deposition of hyaluronic acid (HA) stabilized MnO(2). The nano-reactor could selectively target tumor cells by virtue of surface HA modification, and once internalization, a few reactions were initiated to modulate TME. Glucose was consumed by GOx to inhibit ATP generation, and the produced H(2)O(2) was catalyzed by MnO(2) to generate O(2) for tumor hypoxia alleviation and photodynamic sensitization, and glutathione (GSH) was also effectively depleted by MnO(2) to suppress the tumor antioxidant defense. Consequently, the nano-reactor achieved robust PDT with amplified tumor therapy via intravenous injection. CONCLUSIONS: This nano-reactor offers a multifunctional nanoplatform to sensitize TME-limited tumor treatment means via reversing multiple resistances. GRPAHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-00893-6.
format Online
Article
Text
id pubmed-8139056
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81390562021-05-21 A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances Liu, Peng Zhou, Yanbin Shi, Xinyi Yuan, Yu Peng, Ying Hua, Surong Luo, Qiange Ding, Jinsong Li, Yong Zhou, Wenhu J Nanobiotechnology Research BACKGROUND: Photodynamic therapy (PDT) is a clinically implemented modality to combat malignant tumor, while its efficacy is largely limited by several resistance factors from tumor microenvironment (TME), such as hypoxia, anti-oxidant systems, and ATP-dependent tumor adaptive resistances. The aim of this work is to construct a multifunctional nanoplatform to remodel multiple resistant TME for enhanced PDT. RESULTS: Here, a targeting nano-reactor was facilely constructed to reverse the multiple resistances of PDT by incorporating glucose oxidase (GOx) and chlorin e6 (Ce6) into poly (D, L-lactic-co-glycolic acid) (PLGA)/ metalorganic framework (MOF) coreshell nanoassembly, with surface deposition of hyaluronic acid (HA) stabilized MnO(2). The nano-reactor could selectively target tumor cells by virtue of surface HA modification, and once internalization, a few reactions were initiated to modulate TME. Glucose was consumed by GOx to inhibit ATP generation, and the produced H(2)O(2) was catalyzed by MnO(2) to generate O(2) for tumor hypoxia alleviation and photodynamic sensitization, and glutathione (GSH) was also effectively depleted by MnO(2) to suppress the tumor antioxidant defense. Consequently, the nano-reactor achieved robust PDT with amplified tumor therapy via intravenous injection. CONCLUSIONS: This nano-reactor offers a multifunctional nanoplatform to sensitize TME-limited tumor treatment means via reversing multiple resistances. GRPAHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-00893-6. BioMed Central 2021-05-21 /pmc/articles/PMC8139056/ /pubmed/34020663 http://dx.doi.org/10.1186/s12951-021-00893-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Peng
Zhou, Yanbin
Shi, Xinyi
Yuan, Yu
Peng, Ying
Hua, Surong
Luo, Qiange
Ding, Jinsong
Li, Yong
Zhou, Wenhu
A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances
title A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances
title_full A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances
title_fullStr A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances
title_full_unstemmed A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances
title_short A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances
title_sort cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139056/
https://www.ncbi.nlm.nih.gov/pubmed/34020663
http://dx.doi.org/10.1186/s12951-021-00893-6
work_keys_str_mv AT liupeng acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT zhouyanbin acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT shixinyi acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT yuanyu acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT pengying acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT huasurong acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT luoqiange acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT dingjinsong acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT liyong acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT zhouwenhu acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT liupeng cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT zhouyanbin cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT shixinyi cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT yuanyu cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT pengying cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT huasurong cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT luoqiange cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT dingjinsong cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT liyong cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances
AT zhouwenhu cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances